{"filing":{"accession_number":"0001731122-26-001170","cik":"0001553788","ticker":"SBEVW","company_name":"Endovia Health Sciences, Inc.","form":"8-K","filing_date":"2026-08-28","report_date":"2026-08-25","primary_document":"e7901_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001170/e7901_8-k.htm"},"events":[{"id":30361,"run_id":27824,"accession_number":"0001731122-26-001170","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses an unregistered sale of 510,951 shares of common stock pursuant to a Securities Purchase Agreement with C/M Capital Master Fund, LP, made under Section 4(a)(2) and Rule 506(b) exemptions. This is a classic dilutive equity issuance to a private investor, characteristic of small-cap companies raising capital through private placements. The materiality is evident from the share count and the fact that the purchaser's resales were subsequently registered on Form S-1.","company_name":"Endovia Health Sciences, Inc.","ticker":"SBEVW","filing_date":"2026-08-28","form":"8-K","submitted_at":null,"items":[{"id":32932,"accession_number":"0001731122-26-001170","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses an unregistered sale of 510,951 shares of common stock pursuant to a Securities Purchase Agreement with C/M Capital Master Fund, LP, made under Section 4(a)(2) and Rule 506(b) exemptions. This is a classic dilutive equity issuance to a private investor, characteristic of small-cap companies raising capital through private placements. The materiality is evident from the share count and the fact that the purchaser's resales were subsequently registered on Form S-1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T20:34:53.949593+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32932,"accession_number":"0001731122-26-001170","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses an unregistered sale of 510,951 shares of common stock pursuant to a Securities Purchase Agreement with C/M Capital Master Fund, LP, made under Section 4(a)(2) and Rule 506(b) exemptions. This is a classic dilutive equity issuance to a private investor, characteristic of small-cap companies raising capital through private placements. The materiality is evident from the share count and the fact that the purchaser's resales were subsequently registered on Form S-1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T20:34:53.949593+00:00","company_name":"Endovia Health Sciences, Inc.","ticker":"SBEVW","filing_date":"2026-08-28"}]}